Jilin Aodong Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange:000623.SZ

Location

Market Cap

USD 3.02 B

Share Price

USD 2.52

Avg Daily Volume

9,801,442

Change (1 day)

-0.72%

Change (1 year)

40.04%

Change (YTD)

6.51%

Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin for the year ending December 31, 2024: 70.79%

Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin is 70.79% for the year ending December 31, 2024, a 29.98% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin for the year ending December 31, 2023 was 54.46%, a -25.24% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 72.85%, a -20.13% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 91.21%, a 0.73% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was 90.55%, a 56.50% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin